- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BMS-790052 (NS5A Inhibitor)
Total 1671 results
-
CelgeneActive, not recruitingNeoplasms | Hematologic Malignancies | Hematologic NeoplasmUnited Kingdom, United States
-
The Netherlands Cancer InstituteBristol-Myers SquibbCompletedMalignant Pleural MesotheliomaNetherlands
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Colorectal Adenocarcinoma | Advanced Colon Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Colorectal Carcinoma | Metastatic Rectal Adenocarcinoma | Stage III Colon Cancer AJCC v8 | Stage III Rectal Cancer AJCC v8 | Stage IIIA Colon Cancer AJCC v8 | Stage IIIA Rectal Cancer... and other conditionsUnited States
-
Bristol-Myers SquibbCompletedColorectal Cancer | Pancreatic CancerUnited States, Australia, Belgium, Canada, Germany, Spain
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RecruitingRefractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy | MSI-H TumorsUnited States
-
University of ChicagoCompletedMesothelioma | Peritoneal MesotheliomaUnited States
-
M.D. Anderson Cancer CenterExelixisWithdrawnHepatocellular Carcinoma | Liver CancerUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United States, Mexico, Puerto Rico, Philippines, Russian Federation, Ukraine
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Puerto Rico
-
City of Hope Medical CenterCompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Neuroendocrine Neoplasm | Metastatic Neuroendocrine Carcinoma | Metastatic Large Cell Neuroendocrine Carcinoma | Metastatic Small Cell Neuroendocrine CarcinomaUnited States, Canada
-
Beijing Anzhen HospitalCompletedRandomized Controlled TrialsChina
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; United States Department of Defense; Cancer Prevention...Not yet recruitingMetastatic Renal Cell CarcinomaUnited States
-
Goethe UniversityCompletedPhiladelphia Positive Acute Lymphoblastic LeukemiaGermany
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingMetastatic Renal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Unclassified Renal Cell Carcinoma | Stage II Renal Cell Cancer AJCC v7United States, Canada, Israel
-
Compugen LtdBristol-Myers SquibbActive, not recruitingHead and Neck Cancer | Ovarian Cancer | Solid Tumor | Endometrial NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
Bristol-Myers SquibbCompletedHepatitis B, ChronicAustralia, France, India, Italy, United States, Canada, Poland, Russian Federation, Argentina, South Africa, Brazil, Turkey, Mexico
-
Anwaar SaeedBristol-Myers Squibb; Clovis Oncology, Inc.RecruitingEsophagus Cancer, Adenocarcinoma | Stomach Cancer, AdenocarcinomaUnited States
-
Bristol-Myers SquibbActive, not recruitingRecurrent GlioblastomaPoland, United Kingdom, United States, Spain, Australia, Germany, Italy, Denmark, Belgium, France, Netherlands, Switzerland
-
National Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Recurrent Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell Myeloma | Myeloproliferative Neoplasm | Recurrent... and other conditionsUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
-
M.D. Anderson Cancer CenterBristol-Myers SquibbWithdrawnMultiple Myeloma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrinary Bladder Neoplasms | Muscle-Invasive Bladder CancerRussian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Portugal, Roman... and more
-
National Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Stage II Renal Cell Cancer AJCC v7 | Stage I Renal Cell Cancer AJCC v6 and v7United States
-
Bristol-Myers SquibbCompletedKidney TransplantUnited States
-
Bristol-Myers SquibbCompleted
-
CelgeneCompleted
-
Bristol-Myers SquibbCompletedAutoimmune Diseases | Inflammatory DiseasesUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
Bristol-Myers SquibbCompleted
-
Jeffrey ZonderNot yet recruiting
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Advanced MelanomaUnited States, Netherlands, Spain
-
Suzhou Kintor Pharmaceutical Inc,Active, not recruitingHCC | Hepatocellular CarcinomaUnited States
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
University of California, San FranciscoBristol-Myers Squibb; M.D. Anderson Cancer Center; DendreonCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Japan, Spain, Taiwan, Korea, Republic of, France, Poland, Russian Federation, Turkey
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States, Israel, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Spain, Sweden, Ta... and more
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ppharmaand GmbHBristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaboratorsActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete ResponseUnited States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
-
Bristol-Myers SquibbCompletedChronic Hepatitis BGermany, Italy, France, Spain, Netherlands, Poland, Romania
-
Bristol-Myers SquibbCompletedChronic Hepatitis BKorea, Republic of
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States, Canada
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Vaccinex...CompletedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Colorectal Adenocarcinoma | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Stage I Pancreatic Cancer | Resectable Pancreatic... and other conditionsUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingGastric Cancer | Esophageal Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Czechia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Si... and more
-
Toray Industries, IncCompletedRenal ImpairmentJapan